News

LTS receives grant of $1.2 Million to support the development of thermostable mRNA formulations for Microneedle Array Patches

  • by

​ ANDERNACH, Germany, Dec. 6, 2023 /PRNewswire/ — LTS, a leading pharmaceutical technology company, announced today that it has received a grant from the Bill & Melinda Gates Foundation. The grant will support new formulation methods… Read More »LTS receives grant of $1.2 Million to support the development of thermostable mRNA formulations for Microneedle Array Patches